
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurre... Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.0063 | -14.1940509915 | 21.18 | 22.94 | 18.1737 | 637748 | 21.67202283 | CS |
4 | -1.7463 | -8.76656626506 | 19.92 | 22.94 | 18.1737 | 699954 | 20.79273778 | CS |
12 | -2.1563 | -10.6064928677 | 20.33 | 22.94 | 17.82 | 613226 | 20.11471225 | CS |
26 | -7.2063 | -28.3936170213 | 25.38 | 28.15 | 17.82 | 468723 | 21.63440458 | CS |
52 | -2.1363 | -10.5184638109 | 20.31 | 28.15 | 16.56 | 432814 | 21.57477534 | CS |
156 | 8.5837 | 89.5067778936 | 9.59 | 28.15 | 7.36 | 403863 | 17.05470092 | CS |
260 | 0.0737 | 0.407182320442 | 18.1 | 33 | 7.36 | 402172 | 16.79459194 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions